{"id":"W3012265841","doi":"10.1056/nejmoa1912387","title":"Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1564,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; HLS Therapeutics; Imperial College London; Daiichi Sankyo Europe; Silence Therapeutics; Sanofi; Kowa Company; Novo Nordisk; National Institute for Health and Care Research; Medicines Company; REGENXBIO; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Gilead Sciences; NIHR Imperial Biomedical Research Centre; Singulex; Amgen; Pfizer","keywords":"Ldl cholesterol; Phase (matter); Cholesterol; Internal medicine; Medicine; Chemistry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03953983517206699,"score_gpt":0.3263639915282541,"score_spread":0.2868241563561871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}